secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARIMED INC. (MRMD)
CIK:        0001522767
Form:       8-K
Filed at:   2025-11-05T23:59:59+00:00
Accession:  0001522767-25-000222
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MariMed Q3 revenue $40.8M, adjusted EBITDA $5.1M; expands brands to 3 new states
--------------------------------------------------------------------------------

- Revenue flat at $40.8M (Q3 2024: $40.6M); GAAP net loss widened to $2.9M from $1.0M.
- Adjusted EBITDA rose to $5.1M from $4.7M; margin improved to 13% from 12% YoY.
- Sequential growth in wholesale and retail; new brand distribution agreements in Maine, Pennsylvania, and New York.
- Delaware adult-use sales launched; Metropolis, IL location impacted by new competition.
- Nine-month revenue $118.2M vs $118.8M; GAAP net loss $9.8M vs $4.2M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1522767/000152276725000222/0001522767-25-000222-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1522767/000152276725000222/mrmd-20251105.htm
  HTML page:      https://secwatch.observer/filing/0001522767-25-000222

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer